Understanding human γδ T cell biology toward a better management of cytomegalovirus infection-Reference-Cited by-同舟云学术

Understanding human γδ T cell biology toward a better management of cytomegalovirus infection

Published:2020-10-22 Issue:1 Volume:298 Page:264-288
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:Immunol. Rev.

Author:

Kaminski Hannah¹²^ORCID,Marsères Gabriel¹^ORCID,Cosentino Anaïs¹²,Guerville Florent¹³,Pitard Vincent¹,Fournié Jean‐Jacques⁴,Merville Pierre¹²,Déchanet‐Merville Julie¹^ORCID,Couzi Lionel¹²^ORCID

Affiliation:

1. ImmunoConcEpT UMR 5164 CNRS Bordeaux University Bordeaux France

2. Department of Nephrology, Transplantation, Dialysis and Apheresis Bordeaux University Hospital Bordeaux France

3. CHU Bordeaux Pôle de gérontologie, Bordeaux Bordeaux France

4. Centre de Recherches en Cancérologie de Toulouse (CRCT) UMR1037 INSERM Université Toulouse III: Paul‐Sabatier, ERL5294 CNRS Université de Toulouse Toulouse France

Funder

Agence Nationale de la Recherche

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imr.12922

Reference238 articles.

1. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis

2. Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.

3. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients